Impurities Investigation of ARV-825 Proteolysis Targeting Chimera (PROTAC) Compound through Fraction Collection

Postery | 2025 | Waters | ASMSInstrumentace
LC/MS, LC/SQ
Zaměření
Farmaceutická analýza
Výrobce
Waters
PDF verze ke stažení a čtení
 

Podobná PDF

Impurities Investigation of ARV-825 Proteolysis Targeting Chimera (PROTAC) Compound through Fraction Collection
Degradation Products of ARV-825 Proteolysis Targeting Chimera (PROTAC) Compound: Isolation and Purification Using Analytical Scale Fraction Collection
Isolation of a degradation product of ranitidine hydrochloride using the Waters analytical scale purification system
Small Scale Purification of Fractions from a Complex Pharmaceutical Formulation Using the Waters Fraction Manager-Analytical and an ACQUITY Arc System